Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), sold 21,000 shares at $21.46 ($451K) on 2025-04-15, disclosed to the SEC on 2025-04-16.
Scheduled sale ($451k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.46 | 6,000 | $129K | 28.6% |
| 2 | $21.46 | 15,000 | $322K | 71.4% |
| Total | $21.46 avg | 21,000 | $451K | 100% |
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |